Back to today’s briefing

Story perspectives

Breakthrough Gene Therapy Offers Hope for Dravet Syndrome

3/18/2025

45 3

Summary

Story summary

A groundbreaking gene replacement therapy for Dravet syndrome, a severe epilepsy impacting 1 in 15,700 children, has been developed by scientists at the Allen Institute and Seattle Children’s Research Institute. In treated mice, survival rates improved and symptoms diminished, all without toxicity. This dual AAV delivery method of the SCN1A gene brings renewed hope to families facing this challenging condition.

1 of 1

Story summary

A groundbreaking gene replacement therapy for Dravet syndrome, a severe epilepsy impacting 1 in 15,700 children, has been developed by scientists at the Allen Institute and Seattle Children’s Research Institute. In treated mice, survival rates improved and symptoms diminished, all without toxicity. This dual AAV delivery method of the SCN1A gene brings renewed hope to families facing this challenging condition.